- Activities: Archived NCCN Tumor Boards: Treatment Selection Strategies and Barriers to Clinical Care in Metastatic Breast Cancer , Optimizing Patient Outcomes - Beyond the Package Insert: Appropriate Interpretation of Testing Results for Targeted Therapy Selection, An Interactive Case-Based Review of Chronic Lymphocytic Leukemia: Experts Explore the Latest Evidence and Guideline Updates, Vital Questions for Treatment of Bladder Cancer: Expert Insights on Recent and Near-Future Changes, Recorded Presentation from the NCCN 2024 Pharmacy Updates: Advances in Neoadjuvant Treatment Options in Locally Advanced and Metastatic Rectal Cancer with Deficient Mismatch Repair (dMMR), Recorded Presentation from the 2024 Hematologic Malignancies Congress - The Role of JAK Inhibitors in the Management of Myelofibrosis, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Chronic Myeloid Leukemia: How to Treat During Pregnancy, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Management of TP53 Mutated Mantle Cell Lymphoma, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Evaluation and Treatment of Primary Central Nervous System Lymphoma, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Diagnosis and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Amyloidosis: Diagnosis, Treatment, and Supportive Care, Recorded Presentation from the 2024 Hematologic Malignancies Congress - What is Optimal First-Line Management of Advanced Classic Hodgkin Lymphoma?, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Updates in Prognosis and Treatment, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Diffuse Large B-Cell Lymphoma: Sequencing Therapy for Relapsed/Refractory Disease, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Debate: Is the Addition of Polatuzumab Vedotin the New Standard First-Line Therapy for DLBCL?, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Managing Post-Treatment Complications for Multiple Myeloma and Acute Lymphocytic Leukemia, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Management of Multiple Myeloma: Smoldering, Newly Diagnosed, and Relapsed/Refractory Disease, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Myelodysplastic Syndromes: Treatment Updates and Emerging Data, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Review of Oral Targeted Therapies in Acute Myeloid Leukemia, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Managing Earlier Integration of Blinatumomab in the Treatment of Acute Lymphocytic Leukemia, Recorded Presentation from the 2024 Hematologic Malignancies Congress - Optimizing the Use of Bispecific Antibodies in Hematologic Malignancies, Recorded Presentation from the 2024 Hematologic Malignancies Congress - CAR T-Cell Therapies in Hematologic Malignancies: Challenges and Strategies, Recorded Presentation from the NCCN 2024 Pharmacy Updates: Maintenance Strategies in the Management of Acute Myeloid Leukemia, Archived NCCN Tumor Boards: New Approaches to Treatment of Bladder Cancer, Archived NCCN Tumor Boards: Multidisciplinary Management of Head and Neck Cancers, Recorded Presentation from the NCCN Pharmacy Updates: Chemoimmunotherapy Updates in Advanced/Metastatic Non-Small Cell Lung Cancer, NCCN Guidelines Insights - Soft Tissue Sarcoma, NCCN Guidelines Insights - Breast Cancer, NCCN Guidelines Insights - B-Cell Lymphoma, NCCN Guidelines Insights - Non-Small Cell Lung Cancer, NCCN Guidelines Insights - Uterine Neoplasms, NCCN Guidelines Insights - Thyroid Carcinoma, NCCN Guidelines Insights - Survivorship, NCCN Guidelines Insights - Multiple Myeloma, NCCN Guidelines Insights - Testicular Cancers, NCCN Guidelines Insights - Myelodysplastic Syndromes, NCCN Guidelines Insights - Head and Neck Cancers, NCCN Guidelines Insights - Lung Cancer Screening, Recorded Presentation from the NCCN Pharmacy Updates: Novel Therapies for Treating ESR1 and RET-Fusion Mutations in Breast Cancer, Archived NCCN Tumor Boards: Immune Checkpoint Inhibitors for First-Line Therapy in Esophagogastric/Esophagogastric Junction Cancer, Unraveling Cancer Pain Dynamics (Yale), NCCN 2025 Breast Cancer Congress with Updates from the 2024 San Antonio Breast Cancer Symposium, Recorded Presentation from the NCCN Pharmacy Updates: Updates in the Treatment of Kidney Cancer, Patient Management Simulator: Treatment Recommendations for Kidney Cancer with Management of Immunotherapy-Related Toxicities, Unraveling Cancer Pain Dynamics (City of Hope), Unraveling Cancer Pain Dynamics (University of Colorado), Archived NCCN Tumor Boards: The Role of Molecular Profiling in the Management of Uterine Cancer, Recorded Presentation from the NCCN Pharmacy Updates: What Grade Are You In? The Role of Targeted Therapy in Pediatric Diffuse High-Grade Gliomas, Renal Cell Carcinoma: Evolving Perspectives on Optimal Treatment, Unraveling Cancer Pain Dynamics, Unraveling Cancer Pain Dynamics - Session 4: Interdisciplinary Collaboration in Cancer Pain Management, Unraveling Cancer Pain Dynamics - Session 3: Individualized Opioid Management in Oncology, Unraveling Cancer Pain Dynamics - Session 2: Therapeutic Approaches to Cancer Pain, Unraveling Cancer Pain Dynamics - Session 1: Fundamentals of Cancer Pain Management, Applying NCCN Guidelines for the Treatment of CLL/SLL in Clinical Practice: The Right Agent for the Right Patient at the Right Time, Recorded Presentation from the NCCN Pharmacy Updates: Management of Immunotherapy-Associated Oral Toxicities, Archived Monthly Oncology Tumor Boards - B-Cell Lymphomas: Histologic Transformation of Indolent Lymphomas, Recorded Presentation from the NCCN Pharmacy Updates: Updates in Ovarian Cancer - Putting Together the PARP Puzzle and Understanding a New Therapeutic Target, Recorded Presentation from the NCCN 2024 Annual Conference - Variations in Breast Cancer Screening Recommendations, Recorded Presentation from the NCCN 2024 Annual Conference - Updates to Treatment of Recurrent/Metastatic Head and Neck Cancers, Recorded Presentation from the NCCN 2024 Annual Conference - Updates to the Management of Multiple Myeloma, Recorded Presentation from the NCCN 2024 Annual Conference - Updates to the Management of HR-Positive, HER2-Negative Breast Cancer, Recorded Presentation from the NCCN 2024 Annual Conference - Updates to the Management of Endometrial Cancer, Recorded Presentation from the NCCN 2024 Annual Conference - Updates to the Management of Cutaneous Melanoma, Recorded Presentation from the NCCN 2024 Annual Conference - Updates in the Treatment of Metastatic Urothelial Cancer, Recorded Presentation from the NCCN 2024 Annual Conference - Updates in the Management of Small Cell Lung Cancer, Recorded Presentation from the NCCN 2024 Annual Conference - Updates in the Management of Neuroblastoma, Recorded Presentation from the NCCN 2024 Annual Conference - Updates in the Management of Locally Advanced Rectal Cancer, Recorded Presentation from the NCCN 2024 Annual Conference - Updates in Clinical Management of Pancreatic Cancer, Recorded Presentation from the NCCN 2024 Annual Conference - Team-Based Case Review: Colorectal Cancer, Recorded Presentation from the NCCN 2024 Annual Conference - Team-Based Case Review: Breast Cancer, Recorded Presentation from the NCCN 2024 Annual Conference - Risk Stratification and Selection of Management Strategy for Localized Prostate Cancer, Recorded Presentation from the NCCN 2024 Annual Conference - Plenary Session: Living with Lynch Syndrome: A Patient Story, Recorded Presentation from the NCCN 2024 Annual Conference - New Targeted Therapies for Metastatic Non-Small Cell Lung Cancer, Recorded Presentation from the NCCN 2024 Annual Conference - Management of Trauma-Related and Stressor-Related Disorders, Recorded Presentation from the NCCN 2024 Annual Conference - Management of Renal Cell Carcinoma, Recorded Presentation from the NCCN 2024 Annual Conference - Management of MSI-H/dMMR Upper and Lower Gastrointestinal Cancers, Recorded Presentation from the NCCN 2024 Annual Conference - Management of Cancer-Related Fatigue, Recorded Presentation from the NCCN 2024 Annual Conference - Capturing Structured Data in the Electronic Health Record, Recorded Presentation from the NCCN 2024 Annual Conference - Cancer Risk Reduction Strategies for Transgender, Non-Binary, and Gender Diverse People with Hereditary Cancer Syndromes, Recorded Presentation from the NCCN 2024 Annual Conference - Basal Cell and Squamous Cell Skin Cancers: NCCN Guidelines Updates Based on Risk Status, Recorded Presentation from the NCCN 2024 Annual Conference - Appropriate Vaccinations for Patients in Survivorship, Recorded Presentation from the NCCN 2024 Annual Conference - Acute Myeloid Leukemia: Role of FLT3 Inhibitors After Allogeneic Hematopoietic Cell Transplantation, Recorded Presentation from the NCCN 2024 Annual Conference - The Evolving Role of Advanced Practice Providers in Oncology Care, Recorded Presentation from the NCCN 2024 Annual Conference - Successful Team Care Models: Allocation of Responsibilities and Team Metrics, Recorded Presentation from the NCCN 2024 Annual Conference - Plenary Session: Promising Practices to Reduce the Impact of Drug Shortages on Cancer Care, Recorded Presentation from the NCCN 2024 Annual Conference - Improving Infusion Efficiency to Optimize Oncology Care, Recorded Presentation from the NCCN 2024 Annual Conference - High-Risk Prevention Programs: Identifying Services for High-Risk Patients, Recorded Presentation from the NCCN 2024 Annual Conference - Collection and Utilization of Sex/Sex Characteristics, Sexual Orientation, and Gender Identity (SSOGI) Data, Recorded Presentation from the NCCN 2024 Annual Conference - Changing Economics in Cancer Care: Optimizing Resources and Strategic Tactics to Improve Patient Outcomes and Protect the Workforce, Recorded Presentation from the NCCN 2024 Annual Conference - Best Practices in Care Team Communication Technology, Recorded Presentation from the NCCN 2024 Annual Conference - Balancing Inpatient and Outpatient Oncology Care, Recorded Presentation from the NCCN 2024 Annual Conference - Artificial Intelligence in Oncology, Archived Monthly Oncology Tumor Boards: Updates in Treatment of Hairy Cell Leukemia, Archived NCCN Monthly Oncology Tumor Boards: Management of Pheochromocytoma and Paraganglioma, Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Archived Monthly Oncology Tumor Boards: Systemic Therapy for Metastatic Prostate Cancer, Recorded Presentation from the NCCN 2024 Breast Cancer Congress: Cardiovascular Health After Breast Cancer Treatment, Recorded Presentation from the NCCN 2024 Breast Cancer Congress: Issues with Sexuality and Sexual Function in Patients with Breast Cancer, Recorded Presentation from the NCCN 2024 Breast Cancer Congress: Advances in the Management of Metastatic Breast Cancer with SABCS Updates, Recorded Presentation from the NCCN 2024 Breast Cancer Congress: Locoregional Management of Breast Cancer with SABCS Updates, Recorded Presentation from the NCCN 2024 Breast Cancer Congress: Neoadjuvant/Adjuvant Treatment for Breast Cancer with SABCS Updates, Recorded Presentation from the NCCN 2024 Breast Cancer Congress: Multigene and Biomarker Testing in Breast Cancer, Archived Monthly Oncology Tumor Boards: Sequencing Therapies for Patients with Metastatic HER2-Negative Breast Cancer, Archived Monthly Oncology Tumor Boards: Management of Early-Stage Non-Small Cell Lung Cancer, NCCN Guidelines Insights - Survivorship, NCCN Guidelines Insights - Management of Immunotherapy-Related Toxicities, NCCN Guidelines Insights - Ovarian Cancer, NCCN Guidelines Insights - Colorectal Cancer Screening, NCCN Guidelines Insights - Rectal Cancer, NCCN Guidelines Insights - Cutaneous Melanoma, NCCN Guidelines Insights - Systemic Mastocytosis, NCCN Guidelines Insights - Bladder Cancer, NCCN Guidelines Insights - Prostate Cancer, NCCN Guidelines Insights - Mesothelioma: Pleural, NCCN Guidelines Insights - Kidney Cancer
- Provider Ship: 1
- Provider Address: Plymouth Meeting, PA, USA
- Activity Link: www.nccn.org
- Number of Activities Reported Last Year: 275
- Name of Contact: Karen Kanefield
- Phone Number: (215) 690-0239
- Address: 3025 Chemical Road, Plymouth Meeting, PA, 19462, USA
- Accreditation Status: Joint Accreditation
- Accredited Provider: Joint Accreditation
- Activity Format: Enduring Material, Journal CME/CE, Live Course
Deprecated: File Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /nas/content/live/sleepliteracy/wp-includes/functions.php on line 6121
Leave a Reply